News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
Picking Up the Pace
Kate Yandell | Jan 1, 2016
FDA designations promise to expedite the approval of drugs for conditions ranging from infectious disease to cancer.
The Age of Pharmabrewing
Laura Marengo and John D. Loike | Jan 1, 2016
We should not resist developing opiate-producing GM yeast for fear of the technology falling into the wrong hands.
Jyoti Madhusoodanan | Jan 1, 2016
Phage therapy to combat bacterial infections is garnering attention for the second time in 100 years, but solid clinical support for its widespread use is still lacking.
First Dengue Vax Approved
Kerry Grens | Dec 11, 2015
Mexico’s health ministry has OKed the vaccine for people between nine and 45 years old.
Another Obesity Drug Trial Death
Kerry Grens | Dec 2, 2015
A second patient taking an experimental medication to treat Prader-Willi Syndrome has died of blood clots.
Fatal-Disease Drug in Limbo
Jef Akst | Nov 25, 2015
A panel of experts advised the US Food and Drug Administration that BioMarin Pharmaceutical has not demonstrated efficacy of its new drug for Duchenne muscular dystrophy.
Opinion: Translation Nation
Kathleen Marsman and Lisa McKerracher | Nov 18, 2015
What’s in store for commercialization grants at the Canadian Institutes of Health Research?
Clinical Trial Data Underreported: Study
Kerry Grens | Nov 16, 2015
One-third of the human experiments for approved drugs failed transparency requirements.
Breaching the Blood-Brain Barrier
Jef Akst | Nov 11, 2015
Researchers deliver cancer-fighting drugs to a patient’s brain via the bloodstream, penetrating the blood-brain barrier for the first time.
Battling the Bulge
Bob Grant | Nov 1, 2015
Weight-loss drugs that target newly characterized obesity-related receptors and pathways could finally offer truly effective fat control.